CompletedInterventionalPhase 4Updated Jun 22, 2023
Low Dose Peri- Operative Intra Venous Teranexamic Acid Reduces Blood Loss After Total Knee Arthroplasty: A Double Blind Randomized Placebo... | NCT02327117 | Trialant
Low Dose Peri- Operative Intra Venous Teranexamic Acid Reduces Blood Loss After Total Knee Arthroplasty: A Double Blind Randomized Placebo Controlled Clinical Trial
ClinicalTrials.gov ID
NCT02327117
Lead Sponsor
Isfahan University of Medical SciencesOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
90Actual
Last Update Posted
Jul 22, 2016Estimated
Start Date
Jan 2013
Primary Completion Date
Jan 2015Actual
Brief Summary
Total Knee Arthroplasty (TKA) is a common orthopedic surgery usually leads to Bleeding. The null hypothesis of this study was that TA has no effect on post surgical bleeding in patients undergoes TKA.
Knee Arthroplasty, Total
Tranexamic Acid
Normal saline
Ages Eligible for Study
Child (0-17)Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Individuals with osteoarthritis who indicated for primary TKA.